HKPD (Cellyan Biotechnology Co) FCF Margin %: -4.01% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKPD Cellyan Biotechnology Co Ltd HKPD
21 GF Score
Price $0.44
! 2 Warning Signs
View Full Analysis

What is Cellyan Biotechnology Co FCF Margin %?

Cellyan Biotechnology Co HKPD -4.33% 21 FCF Margin % is -4.01% as of Sep. 2025. GuruFocus rates HKPD with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 115 Medical Distribution companies, Cellyan Biotechnology Co ranks worse than 76.52% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cellyan Biotechnology Co's Free Cash Flow for the six months ended in Sep. 2025 was $-0.29 Mil. Cellyan Biotechnology Co's Revenue for the six months ended in Sep. 2025 was $7.14 Mil. Therefore, Cellyan Biotechnology Co's FCF Margin % for the quarter that ended in Sep. 2025 was -4.01%.

As of today, Cellyan Biotechnology Co's current FCF Yield % is -4.99%.

The historical rank and industry rank for Cellyan Biotechnology Co's FCF Margin % or its related term are showing as below:

HKPD' s FCF Margin % Range Over the Past 10 Years
Min: -3.17   Med: 2.04   Max: 12.81
Current: -3.17

During the past 3 years, the highest FCF Margin % of Cellyan Biotechnology Co was 12.81%. The lowest was -3.17%. And the median was 2.04%.

HKPD's FCF Margin % is ranked worse than
76.52% of 115 companies
in the Medical Distribution industry
Industry Median: 0.97 vs HKPD: -3.17

Cellyan Biotechnology Co FCF Margin % Related Terms

Cellyan Biotechnology Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Cellyan Biotechnology Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellyan Biotechnology Co FCF Margin % Chart

Cellyan Biotechnology Co Annual Data
Trend Mar23 Mar24 Mar25
FCF Margin %
12.81 -2.89 2.04

Cellyan Biotechnology Co Semi-Annual Data
Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
FCF Margin % Get a 7-Day Free Trial -2.34 -3.29 5.83 -2.53 -4.01

HKPD vs COSM, SNYR, YI: FCF Margin % Comparison

For the Medical Distribution subindustry, Cellyan Biotechnology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellyan Biotechnology Co FCF Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cellyan Biotechnology Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cellyan Biotechnology Co's FCF Margin % falls into.


HKPD
21GF Score
Cellyan Biotechnology Co Ltd HKPD
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellyan Biotechnology Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cellyan Biotechnology Co's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=0.414/20.314
=2.04 %

Cellyan Biotechnology Co's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.286/7.137
=-4.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -4.01% mean?
Cellyan Biotechnology Co (HKPD) has a FCF Margin % of -4.01% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cellyan Biotechnology Co and its competitors. According to the industry distribution chart, Cellyan Biotechnology Co ranks #88 out of 115 companies in the Medical Distribution industry, placing it in the top 76.5%.
Is Cellyan Biotechnology Co's FCF Margin % too high?
Cellyan Biotechnology Co's current FCF Margin % is -4.01%. Based on the distribution chart, Cellyan Biotechnology Co ranks #88 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cellyan Biotechnology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Cellyan Biotechnology Co's FCF Margin % compare to COSM and SNYR?
According to the Medical Distribution industry distribution chart, Cellyan Biotechnology Co ranks #88 out of 115 companies for FCF Margin %. This places Cellyan Biotechnology Co in the lower half of its industry. The industry median FCF Margin % is 0.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 0.97, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cellyan Biotechnology Co and its competitors. For the Medical Distribution industry, the median FCF Margin % is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellyan Biotechnology Co's current FCF Margin % is -4.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellyan Biotechnology Co stock overvalued right now?
Cellyan Biotechnology Co (HKPD) has a current FCF Margin % of -4.01%. The current FCF Margin % is -4.01%. Cellyan Biotechnology Co's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cellyan Biotechnology Co (HKPD), the current FCF Margin % is -4.01% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellyan Biotechnology Co Business Description

Address 13 Ko Fai Road, Room B1, 5th Floor, Well Town Industrial Building, Yau Tong, Kowloon, Hong Kong, HKG
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
21GF Score

Get the complete analysis for HKPD

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price